[Use of cabergoline in persisting Cushing's disease].

Illouz, F; Dubois-Ginouves, S; Laboureau, S; Rohmer, V; Rodien, P

[Use of cabergoline in persisting Cushing's disease]. / Utilisation de la cabergoline dans la maladie de Cushing non contrôlée.

Illouz, F; Dubois-Ginouves, S; Laboureau, S; Rohmer, V; Rodien, P.

Affiliation

Illouz F; Service d'Endocrinologie, CHU Hôtel Dieu, 4 rue Larrey, 49033 Angers cedex 01. frillouz@chu-angers.fr

Ann Endocrinol (Paris) ; 67(4): 353-6, 2006 Sep.

Article in Fr | MEDLINE | ID: mdl-17072242

Subject(s)

Adrenocortical Hyperfunction/drug therapy; Ergolines/therapeutic use; Pituitary ACTH Hypersecretion/diagnosis; Adrenocortical Hyperfunction/etiology; Adrenocortical Hyperfunction/surgery; Adult; Cabergoline; Dopamine Agonists/therapeutic use; Female; Humans; Hydrocortisone/urine; Magnetic Resonance Imaging; Middle Aged; Pituitary ACTH Hypersecretion/surgery

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adrenocortical Hyperfunction / Pituitary ACTH Hypersecretion / Ergolines Type of study: Etiology_studies Limits: Adult / Female / Humans / Middle aged Language: Fr Journal: Ann Endocrinol (Paris) Year: 2006 Type: Article

Search on Google

XML

PubMed Links